Trials / Completed
CompletedNCT00226317
Aripiprazole in the Treatment of Bipolar Depression
Phase 4 Study: An Open Prospective Study of the Safety and Effectiveness of Aripiprazole in the Treatment of Bipolar Depression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Cambridge Health Alliance · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
A systematic open-label prospective pilot study to assess aripirazole for acute bipolar depression, with a secondary assessment of longer-term mood stabilization.
Detailed description
Study is 6 weeks long with 7 clinical visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2007-12-01
- Completion
- 2008-02-01
- First posted
- 2005-09-27
- Last updated
- 2017-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00226317. Inclusion in this directory is not an endorsement.